-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation